Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.

Gao, Xueren; Zhang, Shulong; Qiao, Xiaoliang; Yao, Yao; Wang, Limin; Dong, Dong; Ma, Xinxiu; Wang, Taosheng

Gao, Xueren; Zhang, Shulong; Qiao, Xiaoliang; Yao, Yao; Wang, Limin; Dong, Dong; Ma, Xinxiu; Wang, Taosheng.

Afiliação

Gao X; Department of Microbiology and Immunology, Medical College of Southeast University, Nanjing, Jiangsu, China.
Zhang S; Department of General Surgery, Zhongda Hospital, Southeast University Medical School, Nanjing, Jiangsu, China.
Qiao X; Women and Infants Hospital of Zhengzhou, Zhengzhou, Henan, China.
Yao Y; Women and Infants Hospital of Zhengzhou, Zhengzhou, Henan, China.
Wang L; Women and Infants Hospital of Zhengzhou, Zhengzhou, Henan, China.
Dong D; Women and Infants Hospital of Zhengzhou, Zhengzhou, Henan, China.
Ma X; Women and Infants Hospital of Zhengzhou, Zhengzhou, Henan, China.
Wang T; Women and Infants Hospital of Zhengzhou, Zhengzhou, Henan, China.

Cancer Biomark ; 14(4): 287-94, 2014.

Article em En | MEDLINE | ID: mdl-24934372

Assuntos

Antígeno CTLA-4/genética; Neoplasias/genética; Neoplasias/imunologia; Estudos de Casos e Controles; Predisposição Genética para Doença; Humanos; Polimorfismo Genético; Fatores de Risco

Palavras-chave

\CTLA-4; cancer risk; meta-analysis; polymorphism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno CTLA-4 / Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google